Related references
Note: Only part of the references are listed.Molecular mechanisms in cognitive frailty: potential therapeutic targets for oxygen-ozone treatment
Catia Scassellati et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2020)
Oxygen-Ozone (O2-O3) Therapy in Peripheral Arterial Disease (PAD): A Review Study
Hanna Juchniewicz et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2020)
Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients
Morteza Izadi et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Ozone: a natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders
Catia Scassellati et al.
AGEING RESEARCH REVIEWS (2020)
The imbalance of Th17/Treg axis involved in the pathogenesis of preeclampsia
Shadi Eghbal-Fard et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease
Majid Ahmadi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis
Sanam Dolati et al.
JOURNAL OF NEUROIMMUNOLOGY (2019)
Efficacy of comprehensive ozone therapy in diabetic foot ulcer healing
Morteza Izadi et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Therapeutic relevance of ozone therapy in degenerative diseases: Focus on diabetes and spinal pain
Nady Braidy et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial
Sanam Dolati et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators
Sanam Dolati et al.
PHARMACOLOGICAL REPORTS (2018)
Epigenetic Modifications and Therapy in Multiple Sclerosis
Saeed Aslani et al.
NEUROMOLECULAR MEDICINE (2017)
Efficiency of Ozone Therapy in a Rat Model of Experimental Uveitis
Abdullah Kaya et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2017)
Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: Non randomized, open-label clinical trial
Majid Ahmadi et al.
IMMUNOLOGY LETTERS (2017)
Excessive expression of miR-27 impairs Treg-mediated immunological tolerance
Leilani O. Cruz et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Regulatory T cells in multiple sclerosis and myasthenia gravis
K. M. Danikowski et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment
Majid Ahmadi et al.
SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE (2017)
Epigenetic alterations in chronic disease focusing on Behcet's disease: Review
Shahriar Alipour et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
TGF- regulation of encephalitogenic and regulatory T cells in multiple sclerosis
Priscilla W. Lee et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Epigenetic modifications and epigenetic based medication implementations of autoimmune diseases
Majid Ahmadi et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Ozone Therapy in Ethidium Bromide-Induced Demyelination in Rats: Possible Protective Effect
Neveen A. Salem et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)
Ozone: A Multifaceted Molecule with Unexpected Therapeutic Activity
I. Zanardi et al.
CURRENT MEDICINAL CHEMISTRY (2016)
MicroRNA-17 Modulates Regulatory T Cell Function by Targeting Co-regulators of the Foxp3 Transcription Factor
Huang-Yu Yang et al.
IMMUNITY (2016)
Change of Th17 Lymphocytes and Treg/Th17 in Typical and Atypical Optic Neuritis
Hengri Cong et al.
PLOS ONE (2016)
Genetic Association of MiR-146a with Multiple Sclerosis Susceptibility in the Chinese Population
You Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
OZONE AUTOHEMOTHERAPY INDUCES LONG-TERM CEREBRAL METABOLIC CHANGES IN MULTIPLE SCLEROSIS PATIENTS
F. Molinari et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2014)
Effects of ozone therapy and taurine on ischemia/reperfusion-induced testicular injury in a rat testicular torsion model
Tolga Resat Aydos et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2014)
Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms
Azam Jamshidian et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Altered frequency of T regulatory cells is associated with disability status in relapsing-remitting multiple sclerosis patients
Lasse Bjerg et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Ozone in Medicine: The Low-Dose Ozone Concept-Guidelines and Treatment Strategies INTRODUCTION
Renate Viebahn-Haensler et al.
OZONE-SCIENCE & ENGINEERING (2012)
Ozone: A New Therapeutic Agent in Vascular Diseases
Veils Bocci et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2011)
Adjuvant combined ozone therapy for extensive wound over tibia
Prasham Shah et al.
INDIAN JOURNAL OF ORTHOPAEDICS (2011)
MicroRNAs and Multiple Sclerosis
Kemal Ugur Tufekci et al.
AUTOIMMUNE DISEASES (2011)
MicroRNAs and deregulated gene expression networks in neurodegeneration
Kai-Christian Sonntag
BRAIN RESEARCH (2010)
Glucocorticoids increase CD4+CD25high cell percentage and Foxp3 expression in patients with multiple sclerosis
M. Braitch et al.
ACTA NEUROLOGICA SCANDINAVICA (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Regulatory T cells: how do they suppress immune responses?
Shimon Sakaguchi et al.
INTERNATIONAL IMMUNOLOGY (2009)
The Ozone Paradox: Ozone Is a Strong Oxidant as Well as a Medical Drug
Velio Bocci et al.
MEDICINAL RESEARCH REVIEWS (2009)
Transient expression of FOXP3 in human activated nonregulatory CD4(+) T cells
Jun Wang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Scientific and medical aspects of ozone therapy. State of the art
VA Bocci
ARCHIVES OF MEDICAL RESEARCH (2006)
Medical progress: Multiple sclerosis - The plaque and its pathogenesis
EM Frohman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Human RISC couples microRNA biogenesis and posttranscriptional gene silencing
RI Gregory et al.
CELL (2005)
Decreased FOXP3 levels in multiple sclerosis patients
J Huan et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
V Viglietta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs - pilot study
L Tylicki et al.
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS (2001)
Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation
S Read et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
T Takahashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
